ArticleJournal of medical virology2026
Unraveling the Transmission Dynamics of a Novel Norovirus GII.17[P17] Lineage During Two Consecutive Outbreaks in a Spanish Hospital.
Article in Journal of medical virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Unraveling the Transmission Dynamics of a Novel Norovirus GII.17[P17] Lineage During Two Consecutive Outbreaks in a Spanish Hospital.Journal of medical virology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Norovirus outbreaks in healthcare settings pose significant challenges to infection prevention and control (IPC). To prevent and control such outbreaks efficiently, identifying sources and transmission clusters (TCs) is crucial but often limited by traditional outbreak investigations. Here, we examined two consecutive hospital norovirus outbreaks employing a genomic epidemiology approach to elucidate transmission dynamics and guide IPC strategies. Stool samples of 54 symptomatic patients were analyzed with different diagnostic methods, and 26 norovirus-positive samples underwent metagenomic next-generation sequencing (mNGS) for phylodynamic and phylogenetic analyses. All infections belonged to the novel GII.17[P17] lineage, circulating globally since 2023/2024. LiquidArray® outperformed fluorescence immunoassay (FIA, 28.6%) and RT-PCR (85.7%) with FIA's low sensitivity leading to missed cases highlighting the need for molecular confirmation for accurate outbreak management. Genomic analysis revealed multiple introductions, with two TCs identified in Outbreak-1 and one in Outbreak-2, as well as inter-hospital-unit spread. Reconstruction of transmission trees indicated sustained person-to-person spread with 0-3 unobserved intermediate cases in both outbreaks. Identical sequences in patients without clear epidemiological links suggested possible fomite transmission. These analyses provided key insights into infection sources and TCs that would have remained unknown using epidemiological investigations alone, supporting more targeted IPC resource allocation and intervention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.